CARA Cara Therapeutics Inc. Total Business Assets
The current price chart for Cara Therapeutics, Inc. (CARA) serves as an indicator of the business's health, which relies on stable revenue from dialysis-related pruritus therapy but is currently facing a crisis due to the failure of difelikefalin trials and the threat of liquidation. Total assets amount to 30.63. Meanwhile, Cara Therapeutics, Inc. (CARA) is accelerating its search for new drugs, utilizing automated robotic systems for receptor analysis without expanding its headcount.
Analytical breakdowns and data insights for company Cara Therapeutics, Inc (CARA)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Cara Therapeutics, Inc.|CARA - Long-Term Debt to Equity|Current Liabilities to Capital Cara Therapeutics Inc|CARA - Company Aggregate Debts|Debt to Book Value Cara Therapeutics Inc|CARA - Company Long-Term Debts|Company Short-Term Debts Cara Therapeutics|Intermediate Coverage Ratio caratherapeutics.com
- company profitability and valuation multiples indicators:
Fundamental valuation:CARA, caratherapeutics.com
As a portfolio manager, I view the total assets of an enterprise as an integral indicator of its resource base, reverse-calculated via return on assets (ROA) to filter out market noise and identify the real core capital. For Cara Therapeutics, Inc. (CARA), a leader in developing selective drugs for chronic pruritus, this metric reflects the company's ability to convert scientific potential into tangible business value.
Direct competitors
biogen.com (BIIB) - Company Total Assets|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Cumulative Company Assets amylyx.com (AMLX)|Company Total Assets TRVI|Company Total Assets Praxis Precision Medicines Inc (PRAX)|Aggregate Company Assets Anavex Corp AVXL|Aggregate Asset Value CBLL|Prothena Corporation plc - Company Total Assets|ALEC - Company Total Assets|ANNX (Annexon) - Cumulative Company Assets|Omeros - Aggregate Asset Value|Cumulative Company Assets NGNE|ACIU (AC Immune Inc) - Aggregate Business Assets|Company Total Assets VYGR|NMRA (neumoratx.com) - Aggregate Asset Value|Company Total Assets SCLX (Scilex)|Tevogen Bio Holdings Inc. (TVGN) - Company Assets|ACOG - Aggregate Company Assets|Aggregate Asset Value CGTX (Cognition Therapeutics Inc.)|IKT: Company Total Assets|cassavasciences.com (SAVA) - Company Total Assets|Aggregate Company Assets Assertio Holdings|Coya - Total Asset Value of Company|Company Total Assets VTGN|OVID - Company Assets|Acumen Pharmaceuticals - Cumulative Company Assets|Company Total Assets cervomed.com CRVO|ATHE: Cumulative Company Assets|Clene Inc. - Aggregate Business Assets|PEPG: Company Total Assets|JUNS - Company Total Asset Base|RLMD (Relmada Therapeutics) - Company Total Assets|Cumulative Company Assets annovisbio.com (ANVS)|Aggregate Company Assets Grace Therapeutics, Inc. (GRCE)|Company Total Asset Base Firefly Neuroscience, Inc.|Klotho Neurosciences - Cumulative Company Assets|Aggregate Asset Value NRSN|Reviva Pharmaceuticals - Company Total Assets|Company Total Asset Base MetaVia Inc MTVA|NeurAxis (NRXS) - Aggregate Company Assets|Total Business Assets HSDT|PASG (Passage Bio Inc.) - Company Total Assets|Cumulative Company Assets Neuphoria (NEUP)|Cumulative Company Assets NERV (Minerva Neurosciences)|Company Total Asset Base athira.com|Company Total Assets ADXN (Addex Therapeutics Ltd)|ALZN - Cumulative Company Assets|Cyclerion - Company Total Assets|PTIX - Company Total Assets|pasitheaclinics.com (KTTA) - Aggregate Company Assets|Cortigent - Aggregate Asset Value|ATXI (Avenue Therapeutics, Inc.) - Company Total Assets|Company Total Assets Brainstorm Cell Therapeutics Inc.|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|eliemtx.com - Total Business Assets|Company Total Assets ITCI (Intra-Cellular Therapies, Inc.)|longboardpharma.com (LBPH) - Company Assets|MRNS: Cumulative Company Assets|NKGN - Company Total Assets|NeuroBo (NRBO) - Aggregate Company Assets|Sage Therapeutics Inc - Aggregate Asset Value|Aggregate Company Assets Synaptogenix, Inc.|Company Assets trevena.com TRVN|Company Total Assets VIGL|Cumulative Company Assets anewmeds.com WENA|Company Total Assets CERE (Cerevel)